AscellaHealth and Tilde Sciences Team Up to Launch Best-in-Class Patient-Centric Program for Increased Access to Daraprim and Enhanced Patient Outcomes

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, announces that Tilde Sciences, specializing in the development and commercialization of specialty pharmaceuticals, has chosen AscellaHealth’s Specialty Pharmacy, Optime Care as its exclusive distribution, specialty pharmacy and hub/patient services partner. This selection is based upon their impressive track-record for seamlessly launching branded pharmaceutical programs for specialty and rare disease pharma/biotech manufacturers and their exceptional personalized patient care services and resources to support Daraprim®. Through the partnership, patients will experience uninterrupted access to this medication, with distinctive, tailored support programs implemented by expert care coordinators and innovative technology platforms to support custom patient communications, including educational support and interventions at key points in therapy that result in optimal compliance.

To read more, click here.